MCL1 and neuroblastoma: However, in several other cancer types, the CASP8/MCL-1 mRNA ratio did significantly correlate with sensitivity to MEDI3039: ovarian cancer, small-cell lung cancer, neuroblastoma, DLBCL, bladder and skin cancers.